Dental Bone Graft & Substitute Market Production Analysis, Opportunity Assessments, Market Revenue, Advancement Strategy and Geographical Performance Forecast to 2029
The global Dental Bone Graft & Substitute Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6–8% between 2024 and 2029. Market growth is primarily driven by the rising adoption of bone graft procedures, an increasing number of dental implant surgeries, and continuous advancements in regenerative and grafting techniques. Additional contributors include an aging population, growing awareness of oral health, and rapid technological progress in dental care and materials science.
Request
a free sample copy or view report summary:
https://meditechinsights.com/dental-bone-graft-and-substitute-market/request-sample/
Overview
of Dental Bone Graft
A dental bone graft is a surgical procedure used in dentistry to address bone
loss in the jaw caused by conditions such as tooth loss, gum disease, or
trauma. It involves adding bone material to the affected area to restore or
regenerate bone structure. The materials used for bone grafting, known as
substitutes, can come from various sources including:
• Autografts: Bone taken from the patient’s own body, typically from the
hip or jaw.
• Allografts: Donor bone from another human, processed and sterilized to
minimize rejection risk.
• Xenografts: Bone sourced from another species, usually bovine or
porcine, processed for compatibility.
• Synthetic materials: Man-made substances designed to replicate natural
bone properties.
The primary objective of dental bone grafting is to build a stable foundation
for dental implants or restorative treatments that require healthy bone support
for long-term success and integration.
Exploring
Growth Drivers in the Dental Bone Graft and Substitute Sector
The dental bone graft & substitute market is witnessing strong growth
driven by several factors. Increasing cases of dental disorders such as
periodontal disease and tooth decay are leading to higher demand for bone
grafting procedures. The growing preference for dental implants as a tooth
replacement solution is further fueling the need for grafting. Technological
innovations, particularly in synthetic bone substitutes, are propelling market
expansion.
• In April 2023, ZimVie Inc. launched two biomaterial products—RegenerOss CC
Allograft Particulate, combining cortical and cancellous bone particles for
dental applications, and RegenerOss Bone Graft Plug, designed for extraction
sockets and periodontal defects.
Additionally, the aging population and rising awareness of oral health are
driving greater adoption of advanced treatments. Expanding dental tourism,
improved reimbursement policies, and supportive regulations are also
contributing to industry growth. Collectively, these factors are fostering
innovation and broadening the scope of the dental bone graft & substitute
market.
Advancements
Shaping the Landscape of Dental Bone Grafting
Recent trends are transforming the dental bone grafting landscape with
innovations in materials, methods, and digital integration. Development of
next-generation biomaterials with enhanced biocompatibility and osteogenic
properties promises better outcomes. There is rising adoption of minimally
invasive procedures like guided bone regeneration (GBR) and sinus lifts for
reduced discomfort and faster recovery. Growth factor therapies such as bone
morphogenetic proteins (BMPs) and platelet-rich plasma (PRP) are being
increasingly used to stimulate bone formation.
Integration of digital dentistry tools, including cone beam computed tomography
(CBCT), intraoral scanners, and CAD/CAM systems, is improving precision and
customization in grafting.
• In March 2023, Straumann Group introduced multiple digital dentistry
innovations at the International Dental Show in Cologne, such as the Straumann
Falcon navigation system, Smilecloud design platform, and ClearCorrect’s mobile
app for complex treatment collaboration.
Personalized medicine, regenerative therapies like stem cell and tissue
engineering, and sustainable biomaterials are emerging trends that underscore
the industry’s move toward precision, innovation, and eco-conscious
development.
Get Free Sample Report: https://meditechinsights.com/dental-bone-graft-and-substitute-market/request-sample/
Key
Constraints and Challenges
The market faces several challenges including ensuring graft material
compatibility to avoid rejection, maintaining sterility to prevent infection,
and managing procedure costs for better accessibility. Regulatory approvals,
long-term stability, and availability of suitable graft materials are
additional hurdles. Addressing these requires continuous research, innovation,
and collaboration among clinicians, manufacturers, and researchers.
Regional
Outlook: Europe Dominates the Dental Bone Graft & Substitute Market
Europe currently holds the largest share of the dental bone graft &
substitute market, supported by high healthcare spending, an aging population,
and advanced oral care infrastructure. North America also commands a
significant market share, driven by the growing target population and increased
dental implant surgeries. The Asia-Pacific region is projected to experience
rapid growth due to expanding medical tourism, favorable government
initiatives, and a rising elderly population contributing to higher dental
healthcare demand.
Competitive
Landscape
Prominent players in the market include Dentsply Sirona, Straumann, Medtronic
plc, Stryker Corporation, Biohorizons Inc., Zimmer Biomet, RTI Surgical,
Geistlich Pharma AG, Dentium Co. Ltd., and Lifenet Health, among others.
Organic
and Inorganic Growth Strategies Adopted by Key Players
Market participants are leveraging collaborations, partnerships, and
acquisitions to strengthen their market position and expand product portfolios.
• In January 2024, RTI Surgical completed the acquisition of Cook Biotech
Incorporated, enhancing its CDMO capabilities in regenerative medicine.
• In May 2023, Straumann fully acquired GalvoSurge, known for its
peri-implantitis treatment technology.
• In October 2022, Geistlich acquired Lynch Biologics, LLC, adding the GEM 21S
growth factor-based product to accelerate bone formation and healing.
With rising oral health awareness, technological innovation, and strategic
expansion, the Dental Bone Graft & Substitute Market is expected to
maintain strong momentum and deliver significant growth in the years ahead.
About
Medi-Tech Insights
Medi-Tech
Insights is a healthcare-focused business research & insights firm. Our
clients include Fortune 500 companies, blue-chip investors & hyper-growth
start-ups. We have completed 100+ projects in Digital Health, Healthcare IT,
Medical Technology, Medical Devices & Pharma Services in the areas of
market assessments, due diligence, competitive intelligence, market sizing and
forecasting, pricing analysis & go-to-market strategy. Our methodology
includes rigorous secondary research combined with deep-dive interviews with
industry-leading CXO, VPs, and key demand/supply side decision-makers.

Comments
Post a Comment